Literature DB >> 26210129

Systemic Sclerosis: Gastrointestinal Disease and Its Management.

Genevieve Gyger1, Murray Baron2.   

Abstract

The gastrointestinal tract, affecting more than 90% of patients, is the internal organ most frequently involved in systemic sclerosis. Any part of the gastrointestinal tract can be affected, from the mouth to the anus. Patients often experience reduced quality of life and impaired social life. Although only 8% have severe gastrointestinal involvement, mortality is high in those patients. Recent studies on the pathophysiology of the disease highlight new mechanisms to explain gastrointestinal dysmotility, but treatment remains symptomatic. This article reviews the pathophysiology of the gastrointestinal tract and discusses the investigation and management of the disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Constipation; Dysmotility; Esophagus; Fecal incontinence; Gastroesophageal reflux; Gastroparesis; Pseudo-obstruction; Systemic sclerosis

Mesh:

Year:  2015        PMID: 26210129     DOI: 10.1016/j.rdc.2015.04.007

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  30 in total

Review 1.  Chicago Classification of Esophageal Motility Disorders: Applications and Limits in Adults and Pediatric Patients with Esophageal Symptoms.

Authors:  Kornilia Nikaki; Joanne Li Shen Ooi; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2016-11

2.  Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.

Authors:  İpek Türk; Nihan Cüzdan; Volkan Çiftçi; Didem Arslan; Muharrem Cem Doğan; İlker Unal
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

Review 3.  Chronic Intestinal Pseudo-obstruction.

Authors:  Khalil El-Chammas; Manu R Sood
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

4.  Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis.

Authors:  Jingliang Yan; Andrew T Strong; Gautam Sharma; Scott Gabbard; Prashanti Thota; John Rodriguez; Matthew Kroh
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

5.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

Review 6.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

7.  Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.

Authors:  E K Stern; D A Carlson; S Falmagne; A D Hoffmann; M Carns; J E Pandolfino; M Hinchcliff; D M Brenner
Journal:  Neurogastroenterol Motil       Date:  2017-11-06       Impact factor: 3.598

Review 8.  A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.

Authors:  Shannon Teaw; Monique Hinchcliff; Michelle Cheng
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580

9.  Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.

Authors:  Irene Soffritti; Maria D'Accolti; Gloria Ravegnini; Maria-Cristina Arcangeletti; Clara Maccari; Flora De Conto; Adriana Calderaro; Elisabetta Caselli
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

10.  Managing gastrointestinal complications in patients with systemic sclerosis.

Authors:  Z H McMahan; D Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.